skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 193  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients
Material Type:
Article
Add to My Research

Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients

Japanese journal of clinical oncology, 2018-07, Vol.48 (7), p.609-618 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy069 ;PMID: 29767751

Full text available

2
Adult height in relation to the risk of colorectal cancer among the Japanese population: an evaluation based on systematic review and meta-analysis
Material Type:
Article
Add to My Research

Adult height in relation to the risk of colorectal cancer among the Japanese population: an evaluation based on systematic review and meta-analysis

Japanese journal of clinical oncology, 2022-04, Vol.52 (4), p.322-330 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2021 ;The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyab203 ;PMID: 34969070

Full text available

3
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study
Material Type:
Article
Add to My Research

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study

Japanese journal of clinical oncology, 2018-11, Vol.48 (11), p.1012-1021 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy129 ;PMID: 30371895

Full text available

4
A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC
Material Type:
Article
Add to My Research

A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC

Japanese journal of clinical oncology, 2018-12, Vol.48 (12), p.1088-1095 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy136 ;PMID: 30257010

Full text available

5
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset
Material Type:
Article
Add to My Research

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.367-375 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy016 ;PMID: 29474558

Full text available

6
The investigation study using a questionnaire about the employment of Japanese breast cancer patients
Material Type:
Article
Add to My Research

The investigation study using a questionnaire about the employment of Japanese breast cancer patients

Japanese journal of clinical oncology, 2018-08, Vol.48 (8), p.712-717 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy088 ;PMID: 29939297

Full text available

7
A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class
Material Type:
Article
Add to My Research

A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.317-321 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy010 ;PMID: 29474553

Full text available

8
Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer
Material Type:
Article
Add to My Research

Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer

Japanese journal of clinical oncology, 2018-01, Vol.48 (1), p.31-42 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2017 ;The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx144 ;PMID: 29136201

Full text available

9
Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patients
Material Type:
Article
Add to My Research

Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patients

Japanese journal of clinical oncology, 2017-12, Vol.47 (12), p.1182-1188 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx139 ;PMID: 29036563

Full text available

10
Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population
Material Type:
Article
Add to My Research

Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population

Japanese journal of clinical oncology, 2018-08, Vol.48 (8), p.728-735 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy081 ;PMID: 29889250

Full text available

11
Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study
Material Type:
Article
Add to My Research

Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study

Japanese journal of clinical oncology, 2017-05, Vol.47 (5), p.438-446 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. ;The Author 2017. Published by Oxford University Press. 2017 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx011 ;PMID: 28334771

Full text available

12
First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial
Material Type:
Article
Add to My Research

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial

Japanese journal of clinical oncology, 2017-05, Vol.47 (5), p.385-392 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx001 ;PMID: 28158579

Full text available

13
Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset
Material Type:
Article
Add to My Research

Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset

Japanese journal of clinical oncology, 2017-07, Vol.47 (7), p.618-624 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx045 ;PMID: 28369553

Full text available

14
Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors
Material Type:
Article
Add to My Research

Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.322-328 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy026 ;PMID: 29514256

Full text available

15
Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003–13
Material Type:
Article
Add to My Research

Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003–13

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.329-334 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy022 ;PMID: 29506049

Full text available

16
Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia
Material Type:
Article
Add to My Research

Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia

Japanese journal of clinical oncology, 2017-01, Vol.47 (1), p.54-60 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw146 ;PMID: 28122892

Full text available

17
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial
Material Type:
Article
Add to My Research

Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial

Japanese journal of clinical oncology, 2017-06, Vol.47 (6), p.551-559 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. ;The Author 2017. Published by Oxford University Press. 2017 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw194 ;PMID: 28334974

Full text available

18
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062
Material Type:
Article
Add to My Research

Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062

Japanese journal of clinical oncology, 2023-03, Vol.53 (3), p.221-229 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press. 2022 ;The Author(s) 2022. Published by Oxford University Press. ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyac188 ;PMID: 36533429

Full text available

19
An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013
Material Type:
Article
Add to My Research

An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013

Japanese journal of clinical oncology, 2015-04, Vol.45 (4), p.390-401 [Peer Reviewed Journal]

The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyv002 ;PMID: 25637502

Full text available

20
Prognostic awareness in Japanese patients with advanced cancer: a follow-up cohort study
Material Type:
Article
Add to My Research

Prognostic awareness in Japanese patients with advanced cancer: a follow-up cohort study

Japanese journal of clinical oncology, 2023-04, Vol.53 (5), p.410-418 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyad002 ;PMID: 36647604

Full text available

Results 1 - 20 of 193  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2006  (6)
  2. 2006 To 2009  (23)
  3. 2010 To 2013  (70)
  4. 2014 To 2018  (71)
  5. After 2018  (24)
  6. More options open sub menu

Searching Remote Databases, Please Wait